Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin Effect on Attentional Bias in Autistic Traits
NCT02741063Phase 1Unknown
- Sponsor
- University of Electronic Science and Technology of China
- Start
- May 2016
- Primary completion
- Jun 2019
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of oxytocin nasal spray in Autism Spectrum Disorder (ASD) (4 arms), sponsored by University of Electronic Science and Technology of China. Primary endpoint: attentional bias toward emotional expression faces at 1 hour. Status: unknown.
02
Drugs
oxytocin nasal spray
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT02741063.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02741063.